Intact Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,400	Closed	-$687K	–	261
2020 Q4	$687K	Sell	4,400 -3,400	-44%	-$437K	0.02%	212
2020 Q3	$892K	Hold	7,800	–	–	0.03%	189
2020 Q2	$874K	Sell	7,800 -1,000	-11%	-$106K	0.03%	191
2020 Q1	$790K	Buy	8,800 +1,600	+22%	+$157K	0.03%	182
2019 Q4	$778K	Buy	7,200 +3,600	+100%	+$385K	0.03%	195
2019 Q3	$353K	Hold	3,600	–	–	0.01%	211
2019 Q2	$472K	Hold	3,600	–	–	0.02%	196
2019 Q1	$487K	Hold	3,600	–	–	0.02%	191
2018 Q4	$351K	Sell	3,600 -1,400	-28%	-$165K	0.01%	192
2018 Q3	$695K	Sell	5,000 -300	-6%	-$37.6K	0.02%	173
2018 Q2	$658K	Hold	5,300	–	–	0.02%	169
2018 Q1	$591K	Sell	5,300 -200	-4%	-$23.9K	0.02%	168
2017 Q4	$658K	Buy	5,500 +400	+8%	+$48.7K	0.03%	140
2017 Q3	$715K	Sell	5,100 -2,100	-29%	-$285K	0.03%	142
2017 Q2	$876K	Buy	7,200 +1,900	+36%	+$221K	0.04%	134
2017 Q1	$643K	Sell	5,300 -1,300	-20%	-$168K	0.03%	147
2016 Q4	$808K	Buy	6,600 +4,700	+247%	+$575K	0.03%	165
2016 Q3	$233K	Buy	+1,900	New	+$245K	0.01%	256
2016 Q2	–	Sell	-1,500	Closed	-$209K	–	291
2016 Q1	$209K	Buy	1,500 +300	+25%	+$44K	0.01%	261
2015 Q4	$229K	Buy	+1,200	New	+$210K	0.01%	231